Tiger’s Heropanti dominated the box office, earning a lot on the third day too

Through Heropanti 2, Tiger Shroff has once again dominated the hearts and minds of his fans. Only two days have passed since the film was released in theatres, but the craze of the audience towards Tiger Shroff’s Heropanti is worth seeing. Although the film was making a lot of headlines even before its release, but even after its release, it still remains in the headlines due to its earnings. Tiger Shroff, who made his Bollywood debut with Heropanti opposite Kriti Sanon in the year 2014, is seen in Heropanti 2 with Taza Sutaria. On the very first day of release i.e. Friday, where the film was successful in earning about eight crore rupees, on the second day i.e. Saturday also it was successful in earning about 6 crores. It is expected that on the third day of release today, that is, on Sunday, Heropanti 2 can earn 8 to 9 crores at the box office.

Not seeing Tiger Shroff on the big screen for a long time, the restlessness of his fans was increasing. When Tiger Shroff’s Heropanti 2 finally released on 2,500 screens, the theaters thronged to see it. The film is made in the production of Sajid Nadiadwala and it also stars Nawazuddin Siddiqui in an important role along with Tiger Shroff. It would not be wrong to say that due to the collision of Ajay Devgan and Amitabh Bachchan’s film Runway 34, the path of Tiger Shroff’s film was expected to be a bit difficult, but the film’s earnings are telling that Tiger Shroff’s Heropanti In front of Ajay Devgan’s runway 34, not a single one has been able to run.

Tiger Shroff, who returned from Heropanti 2, may have been last seen in Baaghi 3, but now he is going to be seen in big films like Bade Miyan Chote Miyan and Ganpath very soon. The movie Bade Miyan Chote Miyan will also star Akshay Kumar in the lead role along with Tiger Shroff and both have recently announced the film through a teaser. People have also liked it a lot. Fans are now waiting for Tiger Shroff and Akshay Kumar’s film by laying their eyelids.